HOW TO LIVE WITH RHEUMATOID ARTHRITIS???
Journal Title: International Research Journal of Pharmacy (IRJP) - Year 2012, Vol 3, Issue 3
Abstract
Rheumatoid Arthritis (RA) is a chronic auto-immune disease characterized by painful inflammation of the joints and surrounding tissues, leading to long term disability. Rheumatoid arthritis can begin at any age but has its peak between 35 to 55 years of age. RA shows hereditary linkage. Women and smokers are most often affected. The patient doesn’t feel any symptoms during inactive state of the disease. RA progresses in a symmetrical pattern involving both the sides of the body. Once rheumatoid arthritis is confirmed by diagnosis, treatment should start as early as possible. The treatment for rheumatoid arthritis focuses initially on reducing the joint inflammation and pain with the use of analgesics and anti-inflammatory agents. In the next stage, joint function is restored by administering Disease Modifying Anti-rheumatic Drugs (DMARDs) thus preventing joint deformity. Treatment is generally based on the degree of severity of RA. Patients with mild RA are advised to take rest and are prescribed analgesics and anti-inflammatory medicines, which include fast acting drugs like NSAIDs. Slow acting drugs like (DMARDs) such as methotrexate, sulfasalazine, lelflunomide etc., and Body’s reaction modifiers (BRMs) such as rituximab, anankinra, infliximab etc., are reserved for patients suffering from moderate to severe RA. The patient is advised to undertake regular exercises like walking, stretching, swimming or cycling, which are aimed at reducing body weight. The patient suffering from arthritis can carry out his normal day-to-day activities with the help of proper medication and regular exercise.
Authors and Affiliations
Milind Parle , Sushila Kaura
Keywords
Related Articles
- EP ID EP145566
- DOI -
- Views 84
- Downloads 0
IN VITRO ANTIMICROBIAL ACTIVITY OF SELECTED MEDICINAL PLANTS IN LOSHO, NAROK COUNTY KENYA
In Kenya, microbial infections are a major cause of morbidity. Antibiotic effectiveness is threatened by increasing resistance of pathogenic microbes against most available drugs as new pathogens continue to emerge. Curr...
DAPAGLIFLOZIN: SELECTIVE SODIUM-GLUCOSE CO-TRANSPORTER-2 INHIBITOR IN TYPE 2 DIABETES
Dapagliflozin is a promising new drug that targets the so far untapped renal glucose reabsorption. By inhibiting sodium-glucose co-transporter-2 (SGLT2) which is mainly localized in the S1 segment of the proximal tubule,...
ROLE OF NASYA AND SHIROABHYANGA IN THE MANAGEMENT OF ARUNSHIKA (DANDRUFF): A CASE STUDY
Dandruff due to fungus is extremely common, affecting close to 50% of the world's population and it also most prevalent between ages 15 and 50. This study has been conducted to come up With help of Ayurveda, we can give...
FORCED DEGRADATION STUDIES: PRACTICAL APPROACH - OVERVIEW OF REGULATORY GUIDANCE AND LITERATURE FOR THE DRUG PRODUCTS AND DRUG SUBSTANCES
The Objective of the review article is to give a detailed description of the forced degradation studies as per the regulatory guidelines that are associated with various regulatory agencies. This article summarizes the c...
NEBULIZATION THERAPY - A NOVEL APPROACH TO DRUG DELIVERY SYSTEM IN AYURVEDA
The process of Nebulization involves a suspension of fine vaporized liquid droplets--otherwise known as aerosol--to administer fluids, oxygen and liquid medication directly to the respiratory system. Nebulizers are commo...